Ernest S. Smith - Mar 31, 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
SVP, Research & CSO
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Ernest S. Smith
Stock symbol
VCNX
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/3/2023, 04:33 PM
Previous filing
Apr 4, 2022
Next filing
Mar 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 8K Mar 31, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +40K $0.00 40K Mar 31, 2023 Common Stock 40K $0.40 Direct F5
holding VCNX Stock Option (Right to Buy) 40.7K Mar 31, 2023 Common Stock 40.7K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 5.11K Mar 31, 2023 Common Stock 5.11K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 8K Mar 31, 2023 Common Stock 8K $3.90 Direct F1
holding VCNX Stock Option (Right to Buy) 8K Mar 31, 2023 Common Stock 8K $6.07 Direct F2
holding VCNX Stock Option (Right to Buy) 10K Mar 31, 2023 Common Stock 10K $2.93 Direct F3
holding VCNX Stock Option (Right to Buy) 20K Mar 31, 2023 Common Stock 20K $1.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable in full as of the date of this report.
F2 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
F3 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F4 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
F5 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.